This case study explores the collaborative success between SnapStack and Novartis, a global pharmaceutical leader. Focused on adhering to EFPIA (European Federation of Pharmaceutical Industries and Associations) regulations, our project centered around establishing a comprehensive system for monitoring funds provided to medical practitioners by pharmaceutical companies, and assessing its impact within the healthcare ecosystem.
Novartis recognized the importance of compliance with EFPIA regulations, which aim to ensure transparency and ethical interactions between pharmaceutical companies and healthcare professionals. The challenge was to develop a robust system that monitored funds provided to medical practitioners, adhered to EFPIA rules, and enabled Novartis to assess the impact of these interactions on healthcare practices.
Our collaboration with Novartis focused on developing a Fund Monitoring System that aligned with EFPIA regulations. Leveraging our expertise in compliance-driven software solutions, we designed a comprehensive system that tracked and analyzed funds exchanged between Novartis and medical practitioners. The solution aimed to enhance transparency, streamline compliance reporting, and provide valuable insights into the impact of these financial interactions.
The implementation process involved close collaboration with Novartis's compliance and regulatory teams. Our software development experts worked in tandem with internal stakeholders to understand EFPIA regulations, define system requirements, and ensure seamless integration with Novartis's existing processes. The system's deployment included rigorous testing, user training, and ongoing support to ensure sustained compliance.
The deployment of the Fund Monitoring System brought transformative outcomes for Novartis. The system provided a centralized platform for tracking and reporting funds, ensuring EFPIA compliance, and offering valuable insights into the impact of financial interactions with medical practitioners. Novartis experienced enhanced transparency, streamlined compliance processes, and a proactive approach to adhering to EFPIA rules.
The collaborative effort with Novartis delivered substantial benefits, reinforcing the company's commitment to ethical practices and compliance. The Fund Monitoring System not only met regulatory requirements but also empowered Novartis to proactively manage and assess the impact of financial interactions with medical practitioners. Novartis gained enhanced transparency, streamlined reporting, and a strengthened position in the pharmaceutical industry.
The Novartis Fund Monitoring System project highlighted the importance of understanding and aligning with industry regulations. Close collaboration with Novartis's compliance and regulatory teams, expertise in designing compliance-driven solutions, and a focus on transparency and ethical practices were critical elements in achieving success.
"Our collaboration with SnapStack has been instrumental in establishing a robust Fund Monitoring System that aligns with EFPIA regulations. Their expertise in compliance-driven software solutions has significantly enhanced our transparency, streamlined reporting, and proactive management of financial interactions with medical practitioners."
- Compliance Officer at Novartis.
The successful deployment of the Fund Monitoring System for Novartis exemplifies our commitment to delivering compliance-driven solutions that align with industry regulations. It showcases our ability to collaborate closely with pharmaceutical leaders, providing software solutions that enhance transparency, streamline reporting, and foster ethical practices.
Connect with us to explore how our expertise in developing compliance-driven software solutions can be tailored to meet your specific needs, providing a seamless and proactive approach to regulatory adherence.
Headquarters:
Czech Republic,
Křižíkova 53/52a,
186 00 Prague 8
Macedonia,
Mile Pop Jordanov 42-A,
1000 Skopje
Bulgaria,
Gotze Delchev 171/27g,
1404Sofia
Germany,
Nestroystrasse 6,
81373 Munich
UK,
Wenlock Road 20–22,
N17 GU London
Copyrights © 2023 Snapstack
